CVS Health is reportedly closing down a number of its pharmacies installed in Target stores in the United States. The pharmacies are expected to be removed from the discount department store chain’s locations in early 2024.
As per CNN Business, the spokesperson of CVS Health confirmed the closure of its drug stores on Thursday, Jan. 11. It was said that the decision to stop its operations inside the Target outlets comes as retail pharmacy companies in the U.S. are faced with growing difficulties with their workforce, prescriptions business, and other aspects.
Schedule of the Pharmacy Shut Downs
The American retail pharmacy brand said it will close its stores in Target locations from next month until April this year. The company also said this is part of its strategy to spread out its stores and pharmacies even more. This information was shared with CNN through an email from CVS Pharmacy’s spokesperson, Amy Thibault.
The closing of the pharmacies is “based on our evaluation of changes in population, consumer buying patterns and future health needs to ensure we have the right pharmacy format in the right locations for patients,” the spokeswoman said.
Select Locations are Affected
Forbes reported that only select locations of Target stores are losing their CVS Health outlets this year. Then again, the company did not mention specific locations for the shutdown. The company is currently operating around 9,000 stores across the country.
“The pharmacy closures will begin in February and be completed by the end of April and impacted employees will be offered comparable roles within the company,” CVS Health said in a statement. “The closures are part of our plan to realign our national retail footprint and reduce store and pharmacy density and are based on our evaluation of changes in population, consumer buying patterns and future health needs to ensure we have the right pharmacy format in the right locations for patients.”
Photo by: Marques Thomas/Unsplash


Why Maruti Suzuki Is Losing Market Share in India as SUVs and Premium Features Gain Popularity
SpaceX Targets Thursday Launch for Starship's 13th Test Flight After Last-Minute Delay
Lockheed Martin Unveils Lower-Cost Patriot ACE Interceptor to Meet Rising Air Defense Demand
Bank of America Says These Overlooked AI Stocks Could Be the Next Winners
South Korea’s Coupang Fine Sparks U.S. Criticism, Raising Concerns Over Bilateral Ties
Judge Approves Anthropic’s $1.5 Billion AI Copyright Settlement With Authors
Morgan Stanley Downgrades Adobe, Workday as AI Transition Raises Growth Concerns
Seven & i Eyes Żabka Stake in Major European Expansion Push
DeepSeek Eyes $74 Billion Valuation Ahead of Planned China IPO
Chalco Shares Jump as Chinalco Plans Up to $300 Million Stake Increase
Samsung Cuts U.S. Consumer Electronics Jobs as Headquarters Moves to Texas
Trump Criticizes ABC, NBC and CNN for Limiting Coverage of Election Speech
Nationwide Data Center Protests Highlight Growing Backlash Against AI Expansion
Ryanair Warns Summer Airfares May Stay Lower as Quarterly Profit Misses Estimates
Samsung Biologics Launches $1.81 Billion Bid to Acquire PolyPeptide
Foxconn Wins First SpaceX AI Server Contract Worth Estimated $52 Billion
Nvidia Reveals 9.3% Stake in AI Cloud Firm Nebius Following $2 Billion Investment 



